Nathan Bryson

This inventor holds 14 USPTO granted patents and 16 published patent applications and 2 EPO patents, primarily in Sublingual Drug Delivery. Top assignees: Sunovion Pharmaceuticals Inc., Cynapsus Therapeutics, Inc., Arx Limited. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathan Bryson. Retrieved from https://idiyas.com/inventor/nathan-bryson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 16)

% Patents Active = 57.1

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 257(Granted Patents)

Company Filing History:

7 out of 130

Sunovion Pharmaceuticals Inc.

patents

6 out of 6

Cynapsus Therapeutics, Inc.

Field Trip Psychedelics Inc.

patent

where one patent can have more than one assignee

Years Active: 2013-2022

Loading Chart...

Areas of Expertise:

Sublingual Films

Tryptamine Prodrugs

Apomorphine

Drug Delivery

Pharmaceuticals

Bioavailability

Formulations

Pharmacokinetics

Therapeutics

Oral Administration

Rapid Absorption

Patient Compliance

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11419769 - Sublingual films (2022-08-23),

2. 11292765 - Tryptamine prodrugs (2022-04-05),

3. 10420763 - Sublingual apomorphine (2019-09-24),

4. 10285953 - Sublingual films (2019-05-14),

5. 9669021 - Sublingual apomorphine (2017-06-06),

6. 9669020 - Sublingual apomorphine (2017-06-06),

7. 9669019 - Sublingual apomorphine (2017-06-06),

8. 9669018 - Sublingual apomorphine (2017-06-06),

9. 9427412 - Sublingual films (2016-08-30),

10. 9326981 - Sublingual apomorphine (2016-05-03),

11. 9283219 - Sublingual films (2016-03-15),

12. 9044475 - Sublingual apomorphine (2015-06-02),

13. 8846074 - Sublingual films (2014-09-30),

14. 8414922 - Sublingual films (2013-04-09),

Title: Nathan Bryson: Innovating in Pharmacological Solutions

Introduction

Nathan Bryson is a prominent inventor based in Toronto, Canada, recognized for his contributions to the field of pharmacology. With a remarkable portfolio of 14 patents, he has made significant advancements in therapeutic formulations aimed at treating complex medical conditions.

Latest Patents

Among Nathan's recent innovations are two notable patents. The first is for sublingual film formulations designed for dopamine agonists, focusing on treatments for Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders. This invention aims to provide an effective and convenient method of delivering these critical medications. His second patent addresses tryptamine prodrugs, which involves a specific compound that acts as a 5HT2A receptor agonist. This innovation presents a new opportunity for treating depression by converting inactive compounds into therapeutically active forms.

Career Highlights

Nathan has built a formidable career, working with renowned companies in the pharmaceutical sector, including Sunovion Pharmaceuticals Inc. and Cynapsus Therapeutics Inc. His experience in these organizations has played a crucial role in shaping his innovative ideas and understanding the nuances of drug development and delivery systems.

Collaborations

Throughout his career, Nathan has collaborated with notable professionals, including Anthony John Giovinazzo and David Bruce Hedden. These partnerships have enriched his research endeavors and have been instrumental in advancing his inventions.

Conclusion

In conclusion, Nathan Bryson's work exemplifies the spirit of innovation within the pharmaceutical industry. With a growing list of patents and successful collaborations, he continues to push the boundaries of medical science, offering new hope for patients suffering from various disorders. His contributions not only advance therapeutic options but also inspire future generations of inventors in the field.

Profile summary based on public USPTO records.